SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Mobileye Global, Inc. engages in the business of developing and deploying driver assistance systems and autonomous driving technologies and solutions. It operates under the Mobileye and Other segments. The company was founded by Amnon Shashua and Ziv Aviram in 1999 and is headquartered in Jerusalem, Israel.

Mobileye Global Inc - Ordinary Shares - Class A

MOBILEYE GLOBAL INC

Mobileyes shares have sold off to a 52-week low despite a quarterly earnings beat and a modest outlook increase. Bearish traders point to declining revenue, questions about profit quality and concerns over competition and advanced-driver-assistance-system execution, while bulls cite the companys cash position and buyback authorization.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. The firm offers annealing and gate-model quantum computing technologies. It provides professional services that assist customers in identifying and implementing quantum computing applications and selling quantum computer systems to customers. The company was founded by Eric Ladizinsky in 1999 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

QBTS is drawing attention amid a steep selloff and repeated lows, as traders debate whether the decline reflects broader weakness in speculative quantum stocks or concerns about D-Waves valuation, cash burn and the pace of commercialization. Some see the drop as a buying opportunity, while others expect further downside, with bearish options activity adding to the cautious tone.

Basic Attention Token (BAT) is a cryptocurrency launched in 2017and operates on the Ethereum platform. Basic Attention Token has a current supply of 1,500,000,000 with 1,495,724,656.95260575 in circulation. The last known price of Basic Attention Token is 0.13064027 USD and is up 2.94 over the last 24 hours. It is currently trading on 591 active market(s) with $15,372,551.09 traded over the last 24 hours. More information can be found at https://basicattentiontoken.org/.

Basic Attention Token

BAT is drawing attention after a sharp rally and perceived technical breakout, with traders highlighting its relative strength and debating whether momentum can continue or give way to profit-taking and a pullback. No single confirmed token-specific catalyst dominates; some traders point to broader altcoin momentum and Braves expanding ecosystem as supporting narratives.

Air Canada engages in the provision of airline transportation services. Its services cover full-service airline, scheduled passenger and cargo services, serving more than two hundred airports on six continents. It operates through the following geographical segments: Canada, U.S. Transborder, Atlantic, Pacific, and Other. The company was founded on April 11, 1936 and is headquartered in Saint-Laurent, Canada.

Air Canada Inc. - Ordinary Shares (Voting and Variable Voting)

Air Canada Inc.

Air Canadas latest earnings and outlook are driving attention: traders acknowledge strong revenue and demand but focus on surging fuel costs and reduced guidance as pressures on profitability. Some remain bullish on share buybacks and Aeroplans value, while others argue the results and fuel outlook justify the selloff.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

A major Binance security breach has rattled crypto markets and weighed on Bitcoin-linked MSTR, prompting bearish concerns about crypto confidence and further selling alongside dip-buying and hopes for a rebound. Traders are also debating Q3 results, with some noting that reported earnings were largely driven by Bitcoin gains while software revenue fell short of expectations.

United States Natural Gas Fund LP. - United States Natural Gas Fund

United States Natural Gas Fund, LP

Natural gas futures have slid as mild-weather and warm-winter forecasts point to weaker heating demand, with traders also citing ample inventories and supply. Some remain bearish, while others are buying the dip ahead of winter and watching for colder forecasts that could prompt a sharp rebound.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

A strong third-quarter report and raised full-year sales outlook, fueled by demand for Mounjaro and Zepbound, have driven LLYs breakout to record highs. Traders are mostly bullish on continued GLP-1 growth and analyst upgrades, while some question the valuation and flag lower profit guidance and Foundayos slower launch.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in São Paulo, Brazil.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Nu is selling off alongside Brazilian equities after Lulas reelection, as traders reassess Brazils political and economic outlook rather than point to company-specific news. Many view the drop as an overreaction and buying opportunity, while others cite fiscal-policy concerns and Nus exposure to Brazil as risks.

Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.

Mineralys Therapeutics Inc

AstraZenecas early Baxfendy launch sales have disappointed traders and renewed concerns about payer access, competition, and Mineralys ability to commercialize lorundrostat independently. Some argue hypertension launches take time to build coverage and prescribing, while others question the drugs sales potential; the FDA decision and clinical milestones remain key points of focus.

Karman Holdings, Inc. engages in the design, testing, manufacturing, and sale of dependable missile systems. It offers Payload Protection & Deployment Systems, Aerodynamic Interstage Systems, and Propulsion Systems. The company was founded on August 20, 2020 and is headquartered in Huntington Beach, CA.

Karman Holdings Inc.

Karman Holdings Ord Shs

KRMN is drawing attention amid a rebound in defense and drone stocks, with traders pointing to rotation out of tech and optimism around defense demand; some are also positioning ahead of earnings. Fridays pullback was attributed by one trader to a broad market sell-off, while others debated whether the recent strength can hold.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What Makes Acrivon Therapeutics, Inc. (ACRV) a New Buy Stock

Acrivon Therapeutics, Inc. (ACRV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Acrivon Therapeutics, Inc. (ACRV) Just Flashed Golden Cross Signal: Do You Buy?

When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?

Here's Why Acrivon Therapeutics, Inc. (ACRV) is a Great Momentum Stock to Buy

Does Acrivon Therapeutics, Inc. (ACRV) have what it takes to be a top stock pick for momentum investors? Let's find out.

Acrivon Therapeutics (ACRV) Expected to Announce Quarterly Earnings on Wednesday

Acrivon Therapeutics (NASDAQ:ACRV) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 13. (View Earnings Report at...

Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of Acrivon Therapeutics, Inc. (NASDAQ:ACRV - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the six brokerages that are covering the company, Marketbeat.com...

Acrivon Therapeutics (NASDAQ:ACRV) Trading Up 3.2% - Still a Buy?

Acrivon Therapeutics (NASDAQ:ACRV) Trading Up 3.2% - Should You Buy...

Research Analysts Set Expectations for ACRV Q1 Earnings

Acrivon Therapeutics, Inc. (NASDAQ:ACRV - Free Report) - Stock analysts at HC Wainwright raised their Q1 2026 earnings per share estimates for shares of Acrivon Therapeutics in a research report issued on Thursday, March 19th. HC Wainwright analyst E. Bodnar now forecasts that the company will earn...

Acrivon Therapeutics, Inc. (NASDAQ:ACRV - Get Free Report) has been given a consensus rating of "Moderate Buy" by the seven analysts that are currently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold ratin...

Acrivon Therapeutics (NASDAQ:ACRV) Releases Earnings Results, Meets Estimates

Acrivon Therapeutics (NASDAQ:ACRV - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.49) earnings per share (EPS) for the quarter, meeting the consensus...

Acrivon Therapeutics (ACRV) Projected to Post Earnings on Thursday

Acrivon Therapeutics (NASDAQ:ACRV) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 26. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-26-acrivon-therapeutics-inc-stock...

Acrivon Therapeutics, Inc. develops drugs for clinical treatment. Its unique precision medicine platform is Acrivon Predictive Precision Proteomics (AP3). AP3 is used to generate proprietary OncoSignature companion diagnostics to identify patients who will benefit from the medicine. The company was founded by Peter Blume-Jensen and Kristina Masson in 2018 and is headquartered in Watertown, MA.

Acrivon Therapeutics Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

ACRIVON THERAPEUTICS INC

$ACRV CEO said that the upcoming data readout should take place in mid November. We're one month away! Maybe less 🤞.

Jonas

$ACRV this has all the ingredients for an epic blast off just do you have the patience while it cooks

Dani_G_German

$ACRV stock in the speculator hands for the moment. Hopefully the announce of data release will be communicated in next 2 weeks. Then, we will wait for datas.

Lino Polino

$ACRV perfect. November 20th for ACR2316. Now waiting for the Interim date. But possible that will be released on November 9th? We will see. The white horse ready to show somethyng impressive.

$ACRV VOLUMES = ZERO.  With no news or communications it will stay stocked.  But the day will come news is day by day close and someone will start to keep position.......

Feed

News

Sentiment

Earnings

Fundamentals

Info

ACRV ACRIVON THERAPEUTICS INC

Fundamentals

Latest ACRV News